Harvard Drug Group Deceptive Practices Class Action
Last verified October 9, 2026Source: courtlistener-litigationHow ClaimWatch verifies cases
This case was recently filed and is being litigated — the claims below are allegations, not proven facts, and there is no settlement, claim form, or payout yet. Watch the case (right) and we'll email you when it moves, including if it settles and a claim process opens.
What happened
A proposed class action has been filed against The Harvard Drug Group LLC, apparently alleging violations of New York General Business Law § 349 for deceptive practices, along with negligence, strict liability, and unjust enrichment. According to the docket, the court recently granted a motion to dismiss in part, dismissing the Section 349 and unjust enrichment claims with prejudice and allowing limited amendment of the negligence and strict liability claims. These are allegations in a pending case, not proven facts.
Do you qualify?
No settlement exists yet, so there is nothing to file and no class definition to check. If the case settles, the settlement will define exactly who qualifies — watch this case and we'll let you know.
How to file
There is no claim to file yet. If this case reaches a settlement, a claim process will open — usually with an official settlement website and a filing deadline.
Common questions
- Can I file a claim in the Harvard Drug Group Deceptive Practices Class Action case?
- No. This case has been filed and is still being litigated — there is no settlement, no claim form, and no payout. Many class actions are dismissed or never certified, so a case being filed does not mean anyone will be paid. If it settles and a claim process opens, that will be announced by a court-appointed settlement administrator.
- Where is the Harvard Drug Group Deceptive Practices Class Action case being heard?
- The case is before the District Court, S.D. New York, case number 1:24-cv-06223. Everything alleged in the complaint is an allegation, not a proven fact.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More drugs & medical settlements
View all →Anthem Brand Name Drugs Denial of Coverage Settlement
Anthem denied coverage or applied deductibles to brand name (single source) prescription drugs for members with Core 5000, Tonik DN14, Tonik DN15, or RightPlan plans that should have covered these drugs as generic. The settlement requires Anthem to reimburse out-of-pocket expenses for denied brand name drugs and refund deductibles improperly charged. Anthem admits no wrongdoing.
…moreUp to $8,850
MSU Counseling & Mental Health Services Fund
Former doctor Larry Nassar abused patients at Michigan State University's health clinics and through the university's athletics programs. Michigan State University established this fund to reimburse survivors and their eligible family members for out-of-pocket expenses related to mental health treatment.
…more